MagVenture Announces Collaboration with Magnus Medical to Bring the SAINT® Neuromodulation System to Market
ALPHARETTA, Ga., May 1, 2024 /PRNewswire/ -- MagVenture is proud to announce its partnership with Magnus Medical, providing its industry-leading MagPro® magnetic stimulation system to support an exciting new chapter in therapeutic transcranial magnetic stimulation (TMS) through Magnus' SAINT® neuromodulation system.
- ALPHARETTA, Ga., May 1, 2024 /PRNewswire/ -- MagVenture is proud to announce its partnership with Magnus Medical, providing its industry-leading MagPro® magnetic stimulation system to support an exciting new chapter in therapeutic transcranial magnetic stimulation (TMS) through Magnus' SAINT® neuromodulation system.
- Treatment consists of MRI-guided identification of stimulation targets and a proprietary protocol that condenses treatment to just five days.
- "This collaboration underscores our commitment to advancing the treatment of neuropsychiatric disorders and changing people's lives."
- MagVenture and Magnus Medical will exhibit at the upcoming Clinical TMS Society Annual Meeting in London in June where the SAINT system can be seen firsthand.